Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
06/2003
06/05/2003US20030104620 Expression vector for expression of heterologous polypeptides and amplification of cell viral resistance; viricides
06/05/2003US20030104611 Feline immunodeficiency virus gene therapy vectors
06/05/2003US20030104591 Methods and compositions for grafting functional loops into a protein
06/05/2003US20030104573 Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesis
06/05/2003US20030104568 Monitoring electrical transfer between transgenic cell and heart muscle tissue; electroconductivity analysis; tissue engineering
06/05/2003US20030104532 Neuroprotectants; angoigenesis inhibitors; transcription factors
06/05/2003US20030104530 Inhibiting competetive binding; maintenance of organelle equilibrium; drug resistance
06/05/2003US20030104528 Lymphocytes; transcription factors; interferons
06/05/2003US20030104523 Process for high throughput screening of CpG-based immuno-agonist/antagonist
06/05/2003US20030104520 Stable ribozyme for modulation of gene expression; in vitro diagnostic agent; regulatory sequences for medical diagnosis
06/05/2003US20030104518 FIL-1 theta DNAs and polypeptides
06/05/2003US20030104500 Enzymatic assays for screening anti-cancer agents
06/05/2003US20030104455 Methods and compositions for treating urological disorders using 313, 333, 5464, 18817 or 33524
06/05/2003US20030104444 Plasmids for use as tools in treatment and prevention of nervous system, cancer and viral disorders
06/05/2003US20030104419 Method of classifying a thyroid carcinoma using differential gene expression
06/05/2003US20030104406 Modified and stabilized GDF propeptides and uses thereof
06/05/2003US20030104400 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of infammatory, immunol;ogical and nervous system disorders
06/05/2003US20030104399 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of body weight and aging disorders
06/05/2003US20030104045 Novel therapeutic binding molecule complexes
06/05/2003US20030104011 Inactivated reverse transcriptase.
06/05/2003US20030103997 Can be used to inhibit the infectivity, replication and cytopathic effects of a virus, such as a retrovirus, specifically HIV-1 or HIV-2, in the treatment or prevention of viral infection
06/05/2003US20030103992 Cadherin-like asymmetry proteins, in particular, polynucleotides, polypeptides, fusion proteins, and antibodies; for modulating immune response
06/05/2003US20030103987 Contacting cells of patient with protein having toxic activity of Clostridium sordellii toxin LT under conditions favoring inactivating of Ras by glucosylation of Ras'threonine 35 in cells
06/05/2003US20030103986 TACI-immunoglobulin fusion proteins
06/05/2003US20030103974 Administering an antibodies or enzyme inhibitor of prothrombinase; therapeutic treatment of bacterial and viral infections, allograft and xenograft rejection, cancer, glomerulonephritis, gastrointestinal disorders and fetal loss
06/05/2003US20030103952 Anaerobe targeted enzyme-mediated prodrug therapy
06/05/2003US20030103951 Cardiac muscle regeneration using mesenchymal stem cells
06/05/2003US20030103943 Multiple site delivery of adenoviral vector for the induction of angiogenesis
06/05/2003US20030103942 Comprises recombinant adeno-associated virus vectors encoding TNF antagonist; antiinflammatory agents for connective tissues and joints
06/05/2003US20030103941 Administering an interluekin-10 expressing nucleic acid to wound site to promote expression of exogenous interleukin-10 polypeptide
06/05/2003US20030103939 For enhanced transduction of eukaryotic cells; gene expression
06/05/2003US20030103937 Comprises interleukins for enhancing engraphment of bone marrow during transplantation; for treating allergies and blood disorders
06/05/2003CA2852277A1 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
06/05/2003CA2486924A1 Use of t-cell immune response cdna 7 (tirc7) for modulation of angiogenesis and/or neovascularization
06/05/2003CA2468548A1 Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers
06/05/2003CA2468511A1 A method for combined sequential agent delivery and electroporation for cell structures and use thereof
06/05/2003CA2468424A1 A method for combined parallel agent delivery and electroporation for cell structures and use thereof
06/05/2003CA2468408A1 Human cdnas and proteins and uses thereof
06/05/2003CA2468240A1 Muscle transcription factors
06/05/2003CA2468187A1 Peptides with growth inhibitory action
06/05/2003CA2468020A1 Osteopontin-related compositions and methods
06/05/2003CA2467677A1 Compositions of nucleic acids and cationic aminoglycosides and methods of using and preparing the same
06/05/2003CA2467397A1 Flavivirus vaccine delivery system
06/05/2003CA2467202A1 Expression of polypeptides in rod outer segment membranes
06/05/2003CA2466845A1 Manipulation of cytokine levels using cd83 gene products
06/05/2003CA2466478A1 Gene therapy agents for neurodegenerative diseases
06/05/2003CA2466431A1 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
06/05/2003CA2454397A1 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the cns
06/05/2003CA2435758A1 Polynucleotide therapy_against autoantigens for treating insulin dependent diabetes mellitus
06/04/2003EP1316319A1 A novel gene therapy agent for haemophilia b and its preparation method
06/04/2003EP1315970A1 Nucleic acid sequences and proteins involved in cellular senescence
06/04/2003EP1315965A2 Methods and compositions for in vitro targeting
06/04/2003EP1315840A2 Biopanning and rapid analysis of selective interactive ligands (brasil)
06/04/2003EP1315831A2 Stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents
06/04/2003EP1315830A2 Compositions and methods for targeting peptides in humans in vivo
06/04/2003EP1315823A2 Methods for stable transduction of cells with viral vectors
06/04/2003EP1315817A2 18431 and 32374, human protein kinase family members and uses therefor
06/04/2003EP1315814A2 Adhesion molecules
06/04/2003EP1315812A2 Modified polypeptides stabilized in a desired conformation and methods for producing same
06/04/2003EP1315807A2 Chimeric antisense oligonucleotides of arabinofuranose analogues and deoxyribose nucleotides
06/04/2003EP1315798A2 Host cells for packing a recombinant adeno-associated virus (raav), method for the production and use thereof
06/04/2003EP1315794A1 Genetic demonstration of requirement for nkx6.1, nkx2.2 and nkx6.2 in ventral neuron generation
06/04/2003EP1315760A2 Endoglin-specific polypeptide, production and use thereof
06/04/2003EP1315755A1 Anti-angiogenic peptides
06/04/2003EP1315752A1 Modified proteins, isolated novel peptides, and uses thereof
06/04/2003EP1315746A1 Codon optimised recombinant dermaphagoides allergens
06/04/2003EP1315537A1 Method and system for myocardial infarction repair
06/04/2003EP1315523A1 Vp22 protein / nucleic acid aggregates, uses thereof
06/04/2003EP1315519A2 Pharmaceutical compositions and methods useful for modulating angiogenesis
06/04/2003EP1315512A2 Adenoviral targeting and manipulation of immune system response using targeting peptides
06/04/2003EP1315507A2 Hpv-specific short-mers
06/04/2003EP0656007B1 Delta opioid receptor genes
06/04/2003CN1422334A Ecdysone receptor-based inducible gene expression system
06/04/2003CN1421459A Humanized CD3-resisting monoclonal antibody
06/04/2003CN1110564C Adenovirus without viable contaminant particle, preparation and use thereof
06/04/2003CN1110558C Novel growth/differentiation factor of the TGF-ÔÇÿbetaÔÇÖfamily
06/04/2003CN1110556C Isolated nucleic acid molecules for coding tumor rejection antigen precursor MAGE-3 and use thereof
06/03/2003US6573364 Isolation and characterization of Hermansky Pudlak Syndrome (HPS) protein complexes and HPS protein-interacting proteins
06/03/2003US6573360 Human ABH
06/03/2003US6573100 DNA vectors without a selection marker gene
06/03/2003US6573095 Polynucleotides isolated from skin cells
06/03/2003US6573090 Enhanced packaging of herpes virus amplicons and generation of recombinant virus vectors
06/03/2003US6573082 Streptococcus pneumoniae antigens and vaccines
06/03/2003US6573077 Active site of human gamma glutamyl hydrolase
06/03/2003US6573073 Oligonucleotide regulatory sequence that increases promoter activity; vectors; gene therapy for cystic fibrosis; cystic fibrosis transmembrane conductance regulator (CFTR)
06/03/2003US6573071 Given amino acid sequence with a modification resulting in a different processing site; use in treating blood disorders
06/03/2003US6573067 Nucleic acid encoding sodium channels in dorsal root ganglia
06/03/2003US6573050 Reducing expression of tyrosinase related proteins (TYRP2) in cancer cells by contacting the cells with an antisense oligonucleotide targeting mRNA of the protein
06/03/2003US6572881 Delivery of polynucleotides to cells; polylactam
06/03/2003US6572856 Classic complement pathway, C3 convertase
05/2003
05/30/2003WO2003044529A1 Modulators of lymphocyte activation, mkk3b compositions and methods of use
05/30/2003WO2003044524A2 Methods and means for influencing intracellular communication and intracellular organelle transport
05/30/2003WO2003044203A2 Homologous recombination vector, preparations and uses
05/30/2003WO2003044187A2 Emulsion compositions
05/30/2003WO2003044184A1 Treatment of pml targeting jc virus agno
05/30/2003WO2003044172A2 Composition comprising and method of using angiopoietin-like protein 3 angptl3
05/30/2003WO2003044170A2 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
05/30/2003WO2003044162A2 Genes encoding g-protein coupled receptors and methods of use therefor
05/30/2003WO2003043663A1 Compositions inhibiting rejection in organ transplantation and method of using the same
05/30/2003WO2003043649A1 Removal promoters and inhibitor for apoptosis cells in vivo
1 ... 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 ... 870